LEADER 05201nam 2200649 450 001 9910459613903321 005 20200520144314.0 010 $a1-59693-459-X 035 $a(CKB)2670000000047573 035 $a(EBL)946535 035 $a(OCoLC)796382977 035 $a(SSID)ssj0000423086 035 $a(PQKBManifestationID)11289442 035 $a(PQKBTitleCode)TC0000423086 035 $a(PQKBWorkID)10432568 035 $a(PQKB)10405456 035 $a(MiAaPQ)EBC946535 035 $a(Au-PeEL)EBL946535 035 $a(CaPaEBR)ebr10412730 035 $a(CaBNVSL)mat09100672 035 $a(IEEE)9100672 035 $a(EXLCZ)992670000000047573 100 $a20200729d2010 uy 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aMethods in bioengineering $e3D tissue engineering /$fFranc?ois Berthiaume, Jeffrey Morgan, editors 210 1$aBoston :$cArtech House,$dİ2010. 210 2$a[Piscataqay, New Jersey] :$cIEEE Xplore,$d[2010] 215 $a1 online resource (278 p.) 225 1 $aArtech House methods in bioengineering series 300 $aDescription based upon print version of record. 311 $a1-59693-458-1 320 $aIncludes bibliographical references and index. 327 $aChemical modification of porous scaffolds using plasma polymers / Paul Roach, Daniel Howard, John J.A. Barry, Keven M. Shakesheff, Steven M. Howdle, and Morgan R. Alexander -- Three-dimensional cultures in soft self-assembling nanofibers / Nu?ria Mari?-Buye?, Maria Teresa Ferna?ndez Muia?nos, and Carlos E. Semino -- 3D fibrin matrices as scaffolds for depot and release of bioactive molecules / Heike Hall -- Designer self-assembling peptide scaffolds for 3D tissue cell cultures / Fabrizio Gelain, Xiumei Wang, Akihiro Horii, Angus Hucknall, Sotirios Koutsopoulos, and Shuguang Zhang -- Chip-based tissue engineering in microbioreactors / Brigitte Altmann, Stefan Giselbrecht, Matthias Rieke, Alexander Welle, Tim Scharnweber, Karl-Friedrich Weibezahn, and Eric Gottwald -- Affinity-binding alginate scaffolds for the controlled delivery of multiple heparin-binding proteins / Sigalit Amitay-Shaprut, Inbar Freeman, and Smader Cohen -- Self-assembly of cell-laden hydrogels on the liquid-air interface / Benham Zamanian, Nezamoddin N. Kachouie, Mahdokht Masaeli, Jason W. Nichol, and Ali Khademhosseini -- 3D encapsulation of cells in hydrogels using radical and addition cross-linking / Sudhir Khetan, Vyas Ramanan, and Jason A. Burdick -- Micromolded nonadhesive hydrogels for the self-assembly of scaffold-free 3D cellular microtissues / Jacquelyn Youssef, Brian Bao, Toni-Marie Ferruccio and Jeffrey R. Morgan -- On-demand 3D freeform fabrication of tissue structures using bioprinting / Seung- Schik Yoo, Wonhye Lee, Je-Kyun Park -- Three-dimensional neuronal cultures / Michelle C. LaPlaca, Varadraj N. Vernekar, James T. Shoemaker, and D. Kacy Cullen -- Engineering cartilage tissue with zonal properties / June E. Jeon, Jos Malda, Karsten Schrobback, Daisy Irawan, Koichi Masuda, Robert L. Sah, Dietmar W. Hutmacher, and Travis J. Klein -- Cartilage and synovial joint regeneration by cell homing in bioprinted, anatomically correct 3D scaffolds / Chang Hun Lee and Jeremy J. Mao -- Integration of experimental and computational microfluids in 3D tissue engineering / Manuela T. Raimondi, Devin T. Bridgen, Matteo Lagana?, Beatrice Tonnarelli, Margherita Cioffi, Federica Boschetti, and David Wendt. 330 $aThis practical book is part of the new Artech House Methods in Bioengineering series - volumes designed to offer detailed guidance on authoritative methods for addressing specific bioengineering challenges. Written and edited by recognized experts in the field, each book provides research engineers, scientists, and students with step-by-step procedures, clear examples, and effective ways to overcome problems that may be encountered. Tissue engineering is an emerging field that involves the combination of materials, cells, and other signals or growth factors to generate new tissue that can be used to repair or replace damaged tissues due to injury or disease. This groundbreaking volume presents the latest methods and protocols for systematically building tissues in 3D configuration outside the body, as well as providing techniques that modulate repair and regeneration processes that occur "in situ" (in their natural or original place). -- Publisher's description. 410 0$aArtech House methods in bioengineering series. 517 3 $a3D tissue engineering 606 $aTissue engineering 606 $aTransplantation of organs, tissues, etc 606 $aArtificial organs 608 $aElectronic books. 615 0$aTissue engineering. 615 0$aTransplantation of organs, tissues, etc. 615 0$aArtificial organs. 676 $a571.538 702 $aBerthiaume$b Franc?ois$4edt 702 $aMorgan$b Jeffrey Robert$4edt 801 0$bCaBNVSL 801 1$bCaBNVSL 801 2$bCaBNVSL 906 $aBOOK 912 $a9910459613903321 996 $aMethods in bioengineering$91124163 997 $aUNINA LEADER 03845nam 22006974a 450 001 9910452067703321 005 20200520144314.0 010 $a0-19-756195-0 010 $a1-280-83783-7 010 $a0-19-974906-X 010 $a1-4294-0273-3 035 $a(CKB)1000000000465632 035 $a(OCoLC)71794280 035 $a(CaPaEBR)ebrary10375127 035 $a(SSID)ssj0000154401 035 $a(PQKBManifestationID)11149353 035 $a(PQKBTitleCode)TC0000154401 035 $a(PQKBWorkID)10427223 035 $a(PQKB)11512995 035 $a(MiAaPQ)EBC3053633 035 $a(StDuBDS)EDZ0002341412 035 $a(Au-PeEL)EBL3053633 035 $a(CaPaEBR)ebr10375127 035 $a(CaONFJC)MIL83783 035 $a(EXLCZ)991000000000465632 100 $a20050504d2006 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aFibrinolytic and antithrombotic therapy$b[electronic resource] $etheory, practice, and management /$fRichard C. Becker, Frederick A. Spencer 205 $a2nd ed. 210 $aOxford ;$aNew York $cOxford University Press$d2006 215 $a1 online resource (421 p.) 225 1 $aOxford scholarship online 300 $aPreviously issued in print: 2006. 311 $a0-19-515564-5 320 $aIncludes bibliographical references and index. 327 $aHistorical perspectives in hemostasis, coagulation and fibrinolysis -- Vascular biology, thromboresistance and inflammation -- Atherosclerosis and arterial thrombosis -- Venous thromboembolism -- Cardiac chamber, aortic and valvular thromboembolism -- Fibrinolytic agents -- Aspirin -- Clopidogrel -- Platelet Glycoprotein IIb/IIIa receptor antagonists -- Aggrenox and cilostazol -- Novel platelet antagonists -- 327 $aCombination pharmacotherapy -- Facilitated percutaneous coronary intervention -- Thrombin-directed therapy -- Factor Xa inhibitors -- Direct thrombin inhibitors -- Novel anticoagulants -- Acute coronary syndromes -- Peripheral vascular disease and stroke -- Valvular heart disease and atrial fibrillation -- Plaque-stabilizing therapies -- 327 $aVenous thromboembolism prophylaxis -- Venous thromboembolism treatment -- Fundamentals and patient evaluation -- Platelet antagonists -- Anticoagulants -- Anticoagulation clinics and self-testing -- Platelet antagonists -- Anticoagulants -- Fibrinolytic agents. 330 8 $aThrombotic disorders of the circulatory system represent the leading cause of morbidity, mortality, and health care expenditure in the United States. The Second Edition of Fibrinolytic and Antithrombotic Therapy provides a practical, evidence-based approach to the managment of thrombotic disorders for all clinicians involved in the care of patients with these disorders. It provides not only vital conceptual information on fibrinolytic and antithrombotic therapy, but also the means to apply it to everyday decision making and patient care. Focusing on management guidelines and critical pathways, the text stresses practicality and usability. It will be a valuable resource for the wide range of clinicians involved in the care of patients with these disorders. 410 0$aOxford scholarship online. 606 $aThrombolytic therapy 606 $aFibrinolytic agents 606 $aThrombosis$xTreatment 608 $aElectronic books. 615 0$aThrombolytic therapy. 615 0$aFibrinolytic agents. 615 0$aThrombosis$xTreatment. 676 $a616.1/3506 700 $aBecker$b Richard C$044739 701 $aSpencer$b Fredrick A.$cMD.$0887525 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910452067703321 996 $aFibrinolytic and antithrombotic therapy$91982647 997 $aUNINA